In a recent business intelligence study, FactMR presents the nitty-gritty of the global rapid oral fluid screening devices market considering 2013-2017 as the historic year and 2018–2028 as the stipulated time frame. The business report highlights the drivers, restraints, opportunities and trends affecting rapid oral fluid screening devices market growth. Further, all the market shares associated with the market as well as the segments are expressed in terms of value and volume.
The rapid oral fluid screening devices market study outlines the key regions – Latin America, North America, MEA, Europe and APEJ – along with the countries contributing the most in the respective regions. The report presents detailed insights about each market player, including SWOT analysis, main market information, market share, revenue, pricing and gross margin. Prominent players covered in this research are Premier Biotech Inc., UCP Biosciences Inc., OraSure Technologies Inc., Abbott Laboratories and many others.
Worldwide sales of rapid oral fluid screening devices are estimated to surpass 17,700 thousand units in 2019, up from nearly 16,500 units in 2018. The growing demand for of rapid oral fluid screening devices can be attributed to the ever-augmenting cases of drug abuse and alcoholism in many countries across the globe. Tougher regulations and mandates for drug and alcohol testing continue to induce momentum in this market.
The study finds that efficacy of oral fluid for drug testing is being widely acknowledged on account of accuracy and precision of results. Multiple applications, such as pain management, drug treatment, and DUID (driving under influence of drugs) or drug-impaired driving, entail use of rapid oral fluid screening devices for instant yet accurate results. In addition, increasing number of hospital-based laboratories and independent laboratories are making use of rapid oral fluid screening devices to perform multimodal tests.
Request For a Sample Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=2694
As per the research study, oral fluid serves as a viable medium for drug testing, on account of the convenience to collect and low risks of sample adulteration. Results obtained via oral fluid offer better understanding of the impact of drug abuse and seamless evaluation of an individual’s behavioral changes. As per the report, shorter window of time will continue being a key growth inhibitor of rapid oral fluid screening devices market. Drugs ingested in less than around 24 hours and cannabis ingested in less than around 4 hours are effectively detected by these devices, which makes them a misfit in case of challenging and prolonged screening sessions. This, in turn, is likely to pose significant challenges for the manufacturers in the rapid oral fluid screening devices market.